首页/数据集/Abstracts of Chinese companies submitted at ASCO 2023, by company

Abstracts of Chinese companies submitted at ASCO 2023, by company

Statista2026-04-25 收录

肿瘤临床研究

中国制药企业研发

数据链接：

https://www.statista.com/statistics/1398432/papers-of-chinese-companies-at-asco-by-company/数据链接链接失效反馈

官方服务：

资源简介：

Number of clinical research papers submitted by Chinese pharmaceutical enterprises at ASCO 2023, by company

应用场景：

结直肠癌腹膜转移

肿瘤临床研究

Interventions: experiment group:resection of target organs of peritoneal carcinomatosis combined with extensive intraperitoneal lavage Primary outcome(s): 3 year-peritoneal free survival Study Design:

NIAID Data Ecosystem70

Summary of patient cohort.

肿瘤临床研究

生存分析

Comparison of natural history (NH) cohort with chemotherapy (CT) cohort. 1Performance score–performance score using Zubrod scale, 2OS–overall survival, 3MFS–metastatic-free survival, 4response to CT–r

NIAID Data Ecosystem50

Poor Survival in Stage IIB/C (T4N0) compared to Stage IIIA (T1-2N1, T1N2a) Colon Cancer Persists Even after Adjusting for Adequate Lymph Nodes Retrieved and Receipt of Adjuvant Chemotherapy

结肠癌分期预后分析

肿瘤临床研究

Colon 1 study Database Excel file

NIAID Data Ecosystem50

Table_2_Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures.xlsx

肿瘤类器官模型

肿瘤临床研究

BackgroundAlthough biological resources are essential for basic and preclinical research in the oncological field, those of sarcoma are not sufficient for rapid development of the treatment. So far, s

NIAID Data Ecosystem60

clinical data(submit).xls

胆囊癌临床数据

肿瘤临床研究

This data set is a clinical data set of patients with gallbladder cancer.

NIAID Data Ecosystem50